Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSP
3126
BrightSpire Capital
BRSP
$629M
| $876K | ﹤0.01% |
157,477
-64,394
| -29% | -$376K |
|
3127
LSI Industries
LYTS
$912M
| $871K | ﹤0.01% |
51,244
-23,500
| -31% | -$451K |
|
|
TRST
3128
Trustco Bank Corp NY
TRST
$971M
| $871K | ﹤0.01% |
28,569
-10,010
| -26% | -$319K |
|
3129
American Superconductor
AMSC
$1.53B
| $871K | ﹤0.01% |
47,993
-17,910
| -27% | -$447K |
|
3130
Ecovyst
ECVT
$1.1B
| $869K | ﹤0.01% |
140,182
-58,219
| -29% | -$431K |
|
3131
CALL
Mattel
MAT
$4.25B
| $869K | ﹤0.01% |
+44,700
| New | +$887K |
|
3132
Oil States International
OIS
$526M
| $868K | ﹤0.01% |
168,613
-31,057
| -16% | -$163K |
|
3133
Trevi Therapeutics
TRVI
$2.59B
| $868K | ﹤0.01% |
137,932
-18,335
| -12% | -$87.5K |
|
3134
Ceco Environmental
CECO
$4.5B
| $866K | ﹤0.01% |
37,995
-14,621
| -28% | -$390K |
|
3135
Hain Celestial
HAIN
$53.9M
| $866K | ﹤0.01% |
208,589
+13,095
| +7% | +$58.5K |
|
|
FNA
3136
DELISTED
Paragon 28, Inc.
FNA
| $861K | ﹤0.01% |
65,960
-24,698
| -27% | -$307K |
|
3137
Equity Bancshares
EQBK
$1.07B
| $861K | ﹤0.01% |
21,853
-4,530
| -17% | -$190K |
|
3138
First Bank
FRBA
$471M
| $858K | ﹤0.01% |
57,903
+1,237
| +2% | +$18.2K |
|
3139
Castle Biosciences
CSTL
$933M
| $857K | ﹤0.01% |
42,815
-6,198
| -13% | -$153K |
|
3140
Regenxbio
RGNX
$704M
| $856K | ﹤0.01% |
119,659
-7,406
| -6% | -$55.1K |
|
|
VERV
3141
DELISTED
Verve Therapeutics
VERV
| $854K | ﹤0.01% |
186,968
-33,763
| -15% | -$226K |
|
3142
Immunome
IMNM
$3B
| $852K | ﹤0.01% |
126,579
+22,265
| +21% | +$214K |
|
3143
Southern First Bancshares
SFST
$612M
| $849K | ﹤0.01% |
25,777
+465
| +2% | +$16.3K |
|
|
MCHPP
3144
Microchip Technology Inc 7.50% Series A Preferred Stock
MCHPP
| $846K | ﹤0.01% |
+16,800
| New | +$851K |
|
3145
CALL
Roku
ROKU
$22.9B
| $845K | ﹤0.01% |
12,000
-132,700
| -92% | -$10.6M |
|
3146
Business First Bancshares
BFST
$1.05B
| $845K | ﹤0.01% |
34,712
-16,493
| -32% | -$425K |
|
|
BASE
3147
DELISTED
Couchbase
BASE
| $843K | ﹤0.01% |
53,539
-26,981
| -34% | -$447K |
|
3148
Sana Biotechnology
SANA
$1.1B
| $842K | ﹤0.01% |
501,443
+182,960
| +57% | +$511K |
|
|
AVNS
3149
DELISTED
Avanos Medical
AVNS
| $841K | ﹤0.01% |
58,713
-21,488
| -27% | -$335K |
|
3150
Astronics
ATRO
$4.57B
| $841K | ﹤0.01% |
41,770
-21,782
| -34% | -$366K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.